1. © The Author(s) 2015. Published by Science and Education Publishing.
Table 1. Selected open phase II/III trials in platinum resistant ovarian cancer
Trial No
Protocol
Type
NCT
Avelumab with or with out Pegylated Liposomal doxorubicin
Phase III
NCT (COPAIL)
Lurbinectedin Vs PLD or topotecan
NCT
Cediranib & olaparib Vs Chemotherapy
Phase II/III
NCT
Niraparib (single arm)
Phase II
NCT
Pembrolizumab with cisplatin & gemicitabine
NCT
AZD1775 with or without combination chemotherapy
EORTC 55092
Pazopanib in combination with carboplatin/taxol
S.G.D. Ganghadaran et al. Management of Platinum Resistant – Refractory Ovarian Cancer: A Short Review. Journal of
Cancer Research and Treatment, 2016, Vol. 4, No. 2, doi: /jcrt-4-2-3
© The Author(s) Published by Science and Education Publishing.